CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −110 | $580.25 | $64K | 333,833 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −170 | $581.25 | $99K | 333,663 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $582.18 | $163K | 333,383 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $583.61 | $140K | 333,143 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −640 | $584.54 | $374K | 332,503 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,382 | $585.83 | $810K | 331,121 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,108 | $586.72 | $1.2M | 329,013 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,090 | $587.61 | $640K | 327,923 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −835 | $588.59 | $491K | 327,088 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −575 | $590.25 | $339K | 326,513 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −996 | $591.26 | $589K | 325,517 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −514 | $592.05 | $304K | 325,003 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $593.16 | $142K | 324,763 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $594.60 | $119K | 324,563 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $595.19 | $71K | 324,443 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −9,500 | 14,910 | ||
| 2026-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −528 | $587.42 | $310K | 333,415 |
| 2026-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −493 | $588.61 | $290K | 332,922 |
Page 1 of 214 · 4,273 trades